Navigation Links
GNS Healthcare Collaborates with NCI in New Approach to Lung Cancer; Supercomputer Analysis to Aid in Matching Targeted Drugs to Patients
Date:8/13/2011

nts. The results from millions of in silico simulations of these models will provide unique insights into the fundamental mechanisms of NSCLC and its response to drug treatments, enabling the development of more effective treatments for NSCLC.

The initial phase of this project is also intended to help GNS and NCI develop standards for the exchange of data to conduct future collaborations in other relevant mouse model systems.  From this starting point, the groups envision the possibility of a combined experimental and computational work flow aimed at rapidly enabling the generation of hypotheses, testing these hypothesis in silico and in vivo, generating new confirmatory data, and rapidly cycling back to additional computational modeling, with the goal of accelerating the conversion of knowledge into new clinical options for cancer patients.  

About REFS(TM)

REFS(TM) is comprised of integrated machine learning algorithms and software that extract "causal" relationships from complex, multi-dimensional data and enable the simulation of billions of "what if?" hypotheses to explore novel unseen conditions and predictions forward in time. This model-centric discovery and simulation approach represents a paradigm shift in data analysis, leapfrogging existing approaches such as high-dimensional pattern matching. REFS(TM) is licensed to GNS Healthcare from Via Science.

About GNS Healthcare, Inc.

GNS Healthcare (www.gnshealthcare.com), a subsidiary of Via Science, is a healthcare IT company that applies machine learning and simulation technology to optimize patient treatment in partnership with health insurance companies, pharmacy benefit managers, and pharmaceutical & biotech companies. GNS Healthcare is the leading "big data" healthcare analytics firm between drug makers and drug buyers, matching treatments to patients to deliver on the promise of "smart" medic
'/>"/>

SOURCE GNS Healthcare, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology news :

1. GE Healthcare studies report results of [18F]Flutemetamol research
2. GNS Healthcare Collaborates with NCI in New Approach to Lung Cancer; Supercomputer Analysis to Aid in Matching Targeted Drugs to Patients
3. New Healthcare Franchise Opportunity Focuses on Treating Exploding Senior Population
4. Corning, GE Healthcare to receive Technical Achievement Award from Ceramic Society
5. Lexicon to Present Clinical Data for Diabetes Drug Candidate, LX4211, at Two Major Healthcare Conferences
6. Inventor honored for tech improving access to clean water, healthcare, and business development in India
7. The Full Yield, Inc. Launches Breakthrough Collaboration to Put Food Back at the Heart of Healthcare
8. TGen-Scottsdale Healthcare researchers make breakthrough in lung cancer
9. GE Healthcare to evaluate and develop novel imaging technology
10. Scott & White Healthcare researcher finds success with new anti-cancer drug
11. Scott & White Healthcare researcher finds success with new anti-cancer drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2015)... , Aug. 17, 2015 Research ... addition of the "Global Biometric Authentication & ... - Estimation & Forecast, 2015-2020" report to ... authentication and identification systems market is expected to ... 2015 to 2020 and generate over $25 billion ...
(Date:8/12/2015)... 12, 2015 As the digital ... innovation and advanced biometrics technology is accelerating beyond expectations.  ... rely on using their credit cards, the digital currency, ... for payment services led by companies in the space ... Google, Inc. (NASDAQ: GOOG ), Apple Inc. (NASDAQ: ...
(Date:8/11/2015)... 2015 Today, ZUK announced its Android smartphone ... as expected revenues in 2015 that relate to sales of FPC1155 ... of approximately 2,200 MSEK for 2015. Jörgen Lantto, CEO ... prominent smartphone manufacturer in China ... FPC1 155 for Z1 , ...
Breaking Biology News(10 mins):Global Biometric Authentication & Identification Market 2015: Focus On Modality, Motility & Application - Estimation & Forecasts to 2020 for the $25 Billion Industry 2Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 2Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 3Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 4Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 5Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 6FPC's Touch Fingerprint Sensor FPC1155 in ZUK's Smartphone Z1 2
... University biologist has been awarded over $2.3 million from ... of the human pathogen chlamydia in hopes of finding ... disease in the United States. David E. Nelson, ... Arts and Sciences, Department of Biology, and researchers in ...
... invading virus hijacks a cell,s workings by imitating a ... cell signals, the virus destroys a defensive protein designed ... cell cultures, may represent a broader targeting strategy used ... for developing more effective treatments for infectious diseases. ...
... buzz of the golden-winged warbler,s song might not sound like ... population of this little, gray songbird with bright yellow patches ... since 1966. And, as of yet, it remains unprotected by ... dire situation for the warbler, and Ronald Canterbury wants people ...
Cached Biology News:In search for a vaccine, IU biologist receives $2.3 million to explore chlamydia genomics 2In search for a vaccine, IU biologist receives $2.3 million to explore chlamydia genomics 3To drive infections, a hijacking virus mimics a cell's signaling system 2UC research: Saving habitat key to songbird's survival 2
(Date:9/2/2015)... ... 2015 , ... Drug companies increasingly are adopting a business ... in its new report that the U.S. will generate the greatest demand for ... most market demand. , BCC Research examines plant-derived drugs in its report, ...
(Date:9/2/2015)... Australian prostate cancer technology company Minomic International ... recognising ,outstanding, science that uses its patented antibody. ... novel prostate cancer diagnostic test known as MiCheck® next ... out the peer-reviewed Australian Museum Eureka Science Prize for ... This prize is awarded for ground breaking research that ...
(Date:9/2/2015)... Calif. , Sept. 2, 2015 Veracyte, ... Bonnie H. Anderson , president and chief executive officer, ... on Wednesday, September 16, 2015 at 10:30 a.m. ET ... The live audio webcast and subsequent replay ... The webcast will be available shortly after conclusion of ...
(Date:9/2/2015)... ZIONA, Israel , September 2, 2015 ... BVXV) today announced the intent of the National Institute of ... Institutes of Health (NIH) within the Department of Health and ... to be held in the United States ... use of BiondVax,s universal flu vaccine candidate, Multimeric-001 (M-001), as ...
Breaking Biology Technology:Plant-derived Compounds Poised to Assume Greater Role in Global Drug Markets, According to BCC Research 2Plant-derived Compounds Poised to Assume Greater Role in Global Drug Markets, According to BCC Research 3Prostate Cancer Company Minomic Wins Prestigious Eureka Science Prize 2Prostate Cancer Company Minomic Wins Prestigious Eureka Science Prize 3Veracyte to Present at Morgan Stanley Global Healthcare Conference 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3
... LAKE MARY, Fla., Nov. 20 New Generation Biofuels Inc. ... into a Test Burn Agreement with Progress Energy Florida (NYSE: ... boiler applications. , , The Agreement ... test program that will be performed in early 2009 at Progress ...
... 20 Celsis International plc,(LSE: CEL.L), the global ... announced the launch of RapiScreen(TM) Beverage, a new ... company,s proven rapid microbial,screening instrument for dairy products. ... Innovate platform to efficiently and rapidly screen Ultra,Heat ...
... 20 MDV-Mohr Davidow Ventures, a,leading Silicon Valley ... Whiteley and Dan Riskin to the firm as ... start-up,opportunities that provide healthcare providers and consumers more ... prevention to diagnosis to the,treatment of disease. , ...
Cached Biology Technology:New Generation Biofuels Announces Test Burn Agreement With Progress Energy Florida 2New Generation Biofuels Announces Test Burn Agreement With Progress Energy Florida 3Celsis Launches RapiScreen(TM) Beverage Microbial Screening System 2MDV Expands Team Pursuing Advances in Personalized Medicine 2
... mir Vana miRNA Bioarray Essentials Kit provides all ... post-hybridization washing of the mir Vana miRNA ... been labeled using Ambions mir Vana miRNA ... control miRNA (Bioarray ID BA10001) that should be ...
... Intracellular Localization Kit provides a straight forward ... of your design, in an efficient yet ... Subcellular localization and functional inhibition of target ... of the labeled siRNA into mammalian cells. ...
... Tracker Intracellular Localization Kit provides a straight ... siRNA, of your design, in an efficient ... experiments. Subcellular localization and functional inhibition of ... introduction of the labeled siRNA into mammalian ...
... IT siRNA Tracker Intracellular Localization Kit ... straight forward approach to directly label ... in an efficient yet non-destructive manner, ... localization and functional inhibition of target ...
Biology Products: